Search research articles
Contact Us
Filters
Showing results (121-130 of 156) with videos related to
Page
of 16
Sort By:
Cancer
|
April 3, 2014
Choline phosphate cytidylyltransferase-α is a novel antigen detected by the anti-ERCC1 antibody 8F1 with biomarker value in patients with lung and head and neck squamous cell carcinomas
Alec E Vaezi, Gerold Bepler, Nikhil R Bhagwat, et al.
The American Journal of Pathology
|
January 13, 2011
ERCC1 and RRM1 in the international adjuvant lung trial by automated quantitative in situ analysis
Gerold Bepler, Ken André Olaussen, Anne-Lise Vataire, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2006
Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer
Scott J Antonia, Noweeda Mirza, Ingo Fricke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2015
SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer
Erica Hlavin Bell, Arup R Chakraborty, Xiaokui Mo, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
October 29, 2003
Gefitinib (ZD1839) in previously treated advanced non-small-cell lung cancer: experience from a single institution
George R Simon, John C Ruckdeschel, Charles Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2010
Phase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung cancer
Eric B Haura, Tawee Tanvetyanon, Alberto Chiappori, et al.
Cancer
|
April 23, 2014
A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701)
Gerold Bepler, Ralph G Zinner, James Moon, et al.
Scientific Reports
|
October 31, 2018
Chronic p27<sup>Kip1</sup> Induction by Dexamethasone Causes Senescence Phenotype and Permanent Cell Cycle Blockade in Lung Adenocarcinoma Cells Over-expressing Glucocorticoid Receptor
Mugdha Patki, Thomas McFall, Rayna Rosati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2008
Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer
Alberto A Chiappori, Eric Haura, Francisco A Rodriguez, et al.
Oncotarget
|
July 25, 2018
A CARP-1 functional mimetic compound is synergistic with BRAF-targeting in non-small cell lung cancers
Vino T Cheriyan, Hashem Alsaab, Sreeja Sekhar, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 156) with videos related to
Sort By:
Page
of 16
Cancer
|
April 3, 2014
Choline phosphate cytidylyltransferase-α is a novel antigen detected by the anti-ERCC1 antibody 8F1 with biomarker value in patients with lung and head and neck squamous cell carcinomas
Alec E Vaezi, Gerold Bepler, Nikhil R Bhagwat, et al.
The American Journal of Pathology
|
January 13, 2011
ERCC1 and RRM1 in the international adjuvant lung trial by automated quantitative in situ analysis
Gerold Bepler, Ken André Olaussen, Anne-Lise Vataire, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2006
Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer
Scott J Antonia, Noweeda Mirza, Ingo Fricke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2015
SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer
Erica Hlavin Bell, Arup R Chakraborty, Xiaokui Mo, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
October 29, 2003
Gefitinib (ZD1839) in previously treated advanced non-small-cell lung cancer: experience from a single institution
George R Simon, John C Ruckdeschel, Charles Williams, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2010
Phase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung cancer
Eric B Haura, Tawee Tanvetyanon, Alberto Chiappori, et al.
Cancer
|
April 23, 2014
A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701)
Gerold Bepler, Ralph G Zinner, James Moon, et al.
Scientific Reports
|
October 31, 2018
Chronic p27<sup>Kip1</sup> Induction by Dexamethasone Causes Senescence Phenotype and Permanent Cell Cycle Blockade in Lung Adenocarcinoma Cells Over-expressing Glucocorticoid Receptor
Mugdha Patki, Thomas McFall, Rayna Rosati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2008
Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer
Alberto A Chiappori, Eric Haura, Francisco A Rodriguez, et al.
Oncotarget
|
July 25, 2018
A CARP-1 functional mimetic compound is synergistic with BRAF-targeting in non-small cell lung cancers
Vino T Cheriyan, Hashem Alsaab, Sreeja Sekhar, et al.
Page
of 16